Epidemiological and genetic studies have suggested that raised Lp(a) levels are associated with, and have a causal role in, coronary heart disease and calcific aortic valve disease such that those with higher plasma levels of Lp(a) have a higher risk of disease (5–7). The gene discussed is LPA; the disease is coronary artery disorder.